Oxygen targets for preterm infants

Neonatology

Volumn 103, Issue 4, 2013, Pages 341-345

  Stenson, Ben J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Oxygen; Oxygen saturations; Oxygen targets; Preterm; Retinopathy of prematurity

Indexed keywords

OXYGEN;

ARTERIAL GAS; CLINICAL PRACTICE; HOSPITAL DISCHARGE; HUMAN; NEWBORN; NEWBORN CARE; NEWBORN MORTALITY; OXYGEN SATURATION; OXYGEN TENSION; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; PULSE OXIMETRY; RETROLENTAL FIBROPLASIA; REVIEW; TISSUE OXYGENATION;

EID: 84878828900     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000349936     Document Type: Review

References (24)

1. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network, Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Schibler K, Newman NS, Ambalavanan N, Frantz ID 3rd, Piazza AJ, Sánchez PJ, Morris BH, Laroia N, Phelps DL, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O'Shea TM, Bell EF, Ehrenkranz RA, Watterberg KL, Higgins RD. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010; 362: 1959-1969
2. Stenson B, Brocklehurst P, Tarnow-Mordi W. Increased 36-week survival with high oxygen saturation target in extremely preterm infants. UK BOOST II trial; Australian BOOST II trial; New Zealand BOOST II trial. N Engl J Med 2011; 364: 1680-1682
3. Vaucher YE, Peralta-Carcelen M, Finer NN, Carlo WA, Gantz MG, Walsh MC, et al. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med 2012; 367: 2495-2504
4. Terry TL. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely. II. Report of cases-clinical aspects. Trans Am Ophthalmol Soc 1942; 40: 262-284
5. Campbell K. Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach. Med J Aust 1951; 2: 48-50
6. Kinsey VE. Retrolental fibroplasia; cooperative study of retrolental fibroplasia and the use of oxygen. AMA Arch Ophthalmol 1956; 56: 481-543
7. Cross KW. Cost of preventing retrolental fibroplasia? Lancet1973; 2: 954-956
8. Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, et al. PaO 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977; 60: 655-668
9. Yu VY, Hookham DM, Nave JR. Retrolental fibroplasia-controlled study of 4 years' experience in a neonatal intensive care unit. Arch Dis Child 1982; 57: 247-252
10. Bancalari E, Flynn J, Goldberg RN, Bawol R, Cassady J, Schiffman J, Feuer W, Roberts J, Gillings D, Sim E. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987; 79: 663-669
11. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. Trans Am Ophthalmol Soc 1991; 89: 77-92
12. Myers TR. AARC Clinical Practice Guideline: selection of an oxygen delivery device for neonatal and pediatric patients-2002 revision and update. Respir Care 2002; 47: 707-716
13. American Academy of Pediatrics, American College of Obstetricians and Gynecologists, March of Dimes Birth Defects Foundation: Guidelines for Perinatal Care, ed 6. Washington, American Academy of Pediatrics and American College of Obstetricians and Gynecologists, 2007
14. Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks' gestation. Arch Dis Child Fetal Neonatal Ed 2001; 84: F106-F110
15. Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol 2004; 24: 164-168
16. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOPROP), a randomized, controlled trial. I. Primary outcomes. Pediatrics 2000; 105: 295-310
17. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003; 349: 959-967
18. Chow LC, Wright KW, Sola A, CSMC Oxygen Administration Study Group: Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003; 111: 339-345
19. Askie LM, Brocklehurst P, Darlow BA, Finer N, Schmidt B, Tarnow-Mordi W, NeOProM Collaborative Group: NeOProM: Neonatal Oxygenation Prospective Meta-Analysis Collaboration study protocol. BMC Pediatr 2011; 11: 6
20. Johnston ED, Boyle B, Juszczak E, King A, Brocklehurst P, Stenson BJ. Oxygen targeting in preterm infants using the Masimo SET Radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed 2011; 96: F429-F433
21. Saugstad OD, Speer CP, Halliday HL. Oxygen saturation in immature babies: revisited with updated recommendations. Neonatology 2011; 100: 217-218
22. Quine D, Stenson BJ. Arterial oxygen tension (PaO 2 ) values in infants 29 weeks of gestation at currently targeted saturations Arch Dis Child Fetal Neonatal Ed 2009 94 F51-F53
23. Hagadorn JI, Furey AM, Nghiem TH, Schmid CH, Phelps DL, Pillers DA, Cole CH, AVIOx Study Group: Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks' gestation: the AVIOx study. Pediatrics 2006; 118: 1574-1582
24. Claure N, Bancalari E, D'Ugard C, Nelin L, Stein M, Ramanathan R, Hernandez R, Donn SM, Becker M, Bachman T. Multicenter crossover study of automated control of inspired oxygen in ventilated preterm infants. Pediatrics 2011; 127: e76-e83